Silicon Valley Startup Pursues AI-Driven Embryo Gene Editing Despite Global Ban

The article describes a start-up working on gene editing technologies to modify embryos, which likely involves AI systems for complex genetic analysis and editing. While no direct harm has occurred yet, the potential for significant ethical, human rights, and societal harms is credible and plausible, especially given the controversial nature of embryo genetic modification and the exploration of conducting research in countries with more permissive laws. The event does not describe realized harm but highlights a credible risk of future harm, fitting the definition of an AI Hazard rather than an AI Incident or Complementary Information.

The article describes a startup using embryo genetic editing technology, which almost certainly involves AI systems for gene editing design and analysis. The use of such technology to create genetically modified babies is prohibited in many countries and raises significant ethical, health, and societal concerns. Although the article mentions plans and private discussions about creating such babies, it does not confirm that any harm has yet occurred or that a genetically modified baby has been born. Therefore, it does not meet the threshold for an AI Incident but clearly represents a plausible risk of harm due to the AI-enabled technology's use, qualifying it as an AI Hazard.

The article explicitly mentions the use of statistical algorithms and DNA analysis tools to predict embryo traits, which reasonably involves AI systems. The secretive gene-editing experiments, supported by AI-enabled screening, are already underway or planned, indicating the use of AI in development and use phases. The harms include ethical violations, potential human rights breaches, and societal harm through eugenics and unregulated genetic modification. These harms are materialized or ongoing, not merely potential, thus constituting an AI Incident rather than a hazard or complementary information. The involvement of AI in the embryo screening and prediction process is pivotal to the harm and ethical concerns described.